NAYA Biosciences EPS - Earnings per Share 2010-2024 | IVF
NAYA Biosciences eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| NAYA Biosciences Annual EPS |
| 2024 |
$-30.19 |
| 2023 |
$-67.37 |
| 2022 |
$-215.73 |
| 2021 |
$-151.26 |
| 2020 |
$-364.95 |
| 2019 |
$-108.04 |
| 2018 |
$-153.66 |
| 2017 |
$0.00 |
| 2016 |
$-153.66 |
| 2015 |
$-307.32 |
| 2014 |
$-153.66 |
| 2013 |
$-76.83 |
| 2012 |
$-76.83 |
| 2011 |
$-76.83 |
| 2010 |
$-184.39 |
| 2009 |
$-653.06 |
| NAYA Biosciences Quarterly EPS |
| 2024-12-31 |
$-12.66 |
| 2024-09-30 |
$-5.04 |
| 2024-06-30 |
$-7.44 |
| 2024-03-31 |
$-5.04 |
| 2023-12-31 |
$26.99 |
| 2023-09-30 |
$-8.40 |
| 2023-06-30 |
$-36.74 |
| 2023-03-31 |
$-49.22 |
| 2022-12-31 |
$-54.74 |
| 2022-09-30 |
$-50.30 |
| 2022-06-30 |
$-55.46 |
| 2022-03-31 |
$-55.22 |
| 2021-12-31 |
$7.20 |
| 2021-09-30 |
$-57.62 |
| 2021-06-30 |
$-40.82 |
| 2021-03-31 |
$-60.02 |
| 2020-12-31 |
$-144.06 |
| 2020-09-30 |
$-86.44 |
| 2020-06-30 |
$-64.83 |
| 2020-03-31 |
$-69.63 |
| 2019-12-31 |
$-60.50 |
| 2019-09-30 |
$-36.01 |
| 2019-06-30 |
$-11.53 |
| 2019-03-31 |
$0.00 |
| 2018-12-31 |
$-69.07 |
| 2018-09-30 |
$0.00 |
| 2018-06-30 |
$-76.83 |
| 2018-03-31 |
$-7.76 |
| 2017-12-31 |
$0.00 |
| 2017-09-30 |
$0.00 |
| 2017-06-30 |
$0.00 |
| 2017-03-31 |
$0.00 |
| 2016-12-31 |
$-76.83 |
| 2016-09-30 |
$0.00 |
| 2016-06-30 |
$-76.83 |
| 2016-03-31 |
$0.00 |
| 2015-12-31 |
$0.00 |
| 2015-09-30 |
$0.00 |
| 2015-06-30 |
$-307.32 |
| 2015-03-31 |
$0.00 |
| 2011-12-31 |
$-15.37 |
| 2011-09-30 |
$-7.68 |
| 2011-06-30 |
$-30.73 |
| 2011-03-31 |
$-23.05 |
| 2010-12-31 |
$-215.13 |
| 2010-09-30 |
$-30.73 |
| 2010-06-30 |
$-46.10 |
| 2010-03-31 |
$107.56 |
| 2009-12-31 |
$-15.37 |
| 2009-09-30 |
$-484.03 |
| 2009-06-30 |
$-61.47 |
| 2009-03-31 |
$-92.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.001B |
$0.007B |
|
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
|
